References
-
1.
Elimian A1, Garry D, Figueroa R, Spitzer A, Wiencek V, Quirk JG. Antenatal betamethasone compared with dexamethasone (Betacode trial). Obstet. Gynecol. 2007;110:26-30. [PubMed ID: 17601892].
-
2.
Bennet L, Davidson JO, Koome M, Gumm AJ. Glucocorticoids and preterm hypoxic-ischemic brain injury: the good and the bad. J Pregnancy. 2012;2012:751694. [PubMed ID: 22970371].
-
3.
Brownfoot FC, Crowther CA, Middleton P. Different corticosteroid and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst. Rev. 2008;8:CD006764.
-
4.
Lee BH, Stoll BJ, Mc Donalds SA, Higgins RD. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics. 2006;117:1503-10. [PubMed ID: 16651303].
-
5.
Vinukonda G, Dummula K, Malik S, Hu F, Thompson CI, Csiszar A, Ungvari Z, Ballabh P. Effect of prenatal glucocorticoid on cerebral vasculature of the developing brain. Stroke. 2010;41:1766-1773. [PubMed ID: 20616316].
-
6.
Whiteall A, Thoresen M. Antenatal steroids and the developing brain. Arch. Dis. Fetal Neonatal. 2000;83:F154-F157.
-
7.
Spinillo A1, Chiara A, Bergante C, Biancheri D, Fabiana D, Fazzi E. Obstetric risk factors and persistent increases in brain parenchymal echogenicity in preterm infants. BJOG. 2004;11:913-8. [PubMed ID: 15327604].
-
8.
Rippo MR, Villanova F, Tomassoni Ardori F, Graciotti L, Amatori S, Manzotti S, Fanelli M, Gigante A, Procopio A. Dexamethasone affects Fas- and serum deprivation-induced cell death of human osteoblastic cells through survivin regulation. Int. J. Immunopathol. Pharmacol. 2010;23:1153-65. [PubMed ID: 21244764].
-
9.
He L, Liu YP, Hou KZ, Li D, Zhu ZT, Zhang JD. Expression of survivin gene in apoptosis induced by dexamethasone in CEM cells. Zhongguo Dang Dai. Er. Ke. Za. Zhi. 2006;8:173-6. [PubMed ID: 16787583].
-
10.
Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer. 2006;107:746-56. [PubMed ID: 16826583].
-
11.
Conway EM, Zwerts F, Van Eygen V, DeVriese A, Nagai N, Luo W, Collen D. Survivin-dependent angiogenesis in ischemic brain: molecular mechanism of hypoxia-induced up-regulation. Am. J. Pathol. 2003;163:935-946. [PubMed ID: 12937134].
-
12.
Li F, Brattain MG. Role of the survivin Gene in pathophysiology. Am. J. Pathol. 2006;169:1-11. [PubMed ID: 16816356].
-
13.
Huo Y, Rangarajan P, Ling EA, Dheen ST. Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC Neurosci. 2011;12:49. [PubMed ID: 21615929].
-
14.
Ain R, Canham LN, Soares MJ. Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the AKT signaling pathway. J. Endocrinol. 2005;185:253-63. [PubMed ID: 15845918].
-
15.
Zhang Y, Park TS, Gidday JM. Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am. J. Physiol. Heart Circ. Physiol. 2007;292:H2573-H2581. [PubMed ID: 17337592].
-
16.
Wei L, Wang H, Kuang CY, Zhu JK, Yu Y, Qui ZX. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol. Cell. Biochem. 2012;363:135-145. [PubMed ID: 22139302].